Clinical Trial Update: Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B

View source ↗

Summary

This clinical trial update describes a recruiting study evaluating the role of SGLT2 inhibitors in reducing cardiotoxicity from anthracyclines and in breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: Centre Paul Strauss | Conditions: Breast Neoplasms | Status: RECRUITING